Nizatidine. Axid 18090 . LY-139037 . N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine . LY 139037 . LY139037 . A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers. . 1.00
Raloxifene Hydrochloride. Evista . Keoxifene . Keoxifene Hydrochloride . LY 139481 . LY 156758 . LY-139481 . LY-156758 . Raloxifene HCl . LY139481 . LY156758 . Raloxifene . LY 156758 . A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue. . 0.66
p-Chloroamphetamine. LY-121860 . Ly-123362 . Parachloroamphetamine . LY 121860 . LY121860 . Ly 123362 . Ly123362 . p Chloramphetamine . p Chloroamphetamine . para Chloroamphetamine . p-Chloramphetamine . para-Chloroamphetamine . Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool. . 0.44
Moxalactam. 6059-S . Disodium Latamoxef . Disodium Moxalactam . Festamoxin . Lamoxactam . Latamoxef . Lilly 127935 . Ly-127935 . Ly127935 . Moxalactam Disodium . S-6059 . Shiomarin . 1 Oxacephalosporin . 6059 S . 6059S . Disodium, Moxalactam . Latamoxef, Disodium . Ly 127935 . Moxalactam, Disodium . S 6059 . S6059 . 1-Oxacephalosporin . Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. . 0.44
Pergolide. Celance . LY-127,809 . LY-127809 . Parkotil . Pergolide Mesylate . Permax . Pharken . LY127,809 . LY127809 . Mesylate, Pergolide . PERGOLIDE MESYLATE . A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES. . 0.44